The vascular biology of macrophage migration inhibitory factor (MIF) Expression and effects in inflammation, atherogenesis and angiogenesis

Yaw Asare, Martin Schmitt, Juergen Bernhagen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine with chemokine-like functions. MIF is a critical mediator of the host 'immune and inflammatory response. Dysregulated MIF expression has been demonstrated to contribute to various acute and chronic inflammatory conditions as well as cancer development. More recently, MIF has been identified as an important pro-atherogenic factor. Its blockade could even aid plaque regression in advanced atherosclerosis. Promotion of atherogenic leukocyte recruitment processes has been recognised as a major underlying mechanism of MIF in vascular pathology. However, MIF's role in vascular biology is not limited to mune cell recruitment as recent evidence also points to a role for this I mediator in neo-angiogenesis / vasculogenesis by endothelial cell activation and endothelial progenitor cell recruitment. On the basis of introducing MIF's chemokine-like functions, the current article focusses on MIF's role in vascular biology and pathology.
Original languageEnglish
Pages (from-to)391-398
JournalThrombosis and Haemostasis
Issue number3
Publication statusPublished - Mar 2013


  • Chemokine
  • monocyte/macrophage
  • cardiovascular disease
  • atherosclerosis
  • (neo-)angiogenesis/vasculogenesis

Cite this